62406 Federal Register / Vol. 75, No. 195 / Friday, October 8, 2010 / Notices 

in the voluntary paternity establishment 

program. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

None ................................................................................................................ 1,167,097 1 .166 193,738 

Estimated Total Annual Burden 

Hours: 193,738. 

In compliance with the requirements 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; 

(c) the quality, utility, and clarity of the 

information to be collected; and 

(d) ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: September 29, 2010. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2010–25023 Filed 10–7–10; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Plan To Develop a Genetic Testing 

Registry at the National Institutes of 

Health; Public Meeting; Request for 

Comments 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice of public meeting; 

request for comments. 

SUMMARY: The National Institutes of 

Health is announcing a public meeting 

to gather stakeholder perspectives on its 

plan to develop the Genetic Testing 

Registry. The meeting will provide a 

forum for interested stakeholders to 

provide comments on specific aspects of 

the plan. 

Date and Time: The public meeting 

will be held November 2, 2010, from 9 

a.m. to 12 p.m. 

Location: The public meeting will be 

held at the Walter E. Johnson 

Convention Center, Room 147, 801 

Mount Vernon Place, NW., Washington, 

DC 20001. For directions, please contact 

the Convention Center at 202–249–3000 

or refer to the following Web site: 

http://www.dcconvention.com/. 

Special accommodations: Anyone 

planning to attend the meeting who 

needs special assistance, such as sign 

language interpretation or other 

reasonable accommodations, is asked to 

contact Cathy Fomous (see Contacts 

section) by October 26, 2010. 

Registration: If you wish to attend the 

public meeting, please register by 

October 27, 2010. Registration is free 

and on a first-come, first-served basis. 

Pre-registration can be completed online 

at http://oba.od.nih.gov/gtr/ 

gtr_meetings.html. Persons without 

Internet access may call Ms. Nicole 

Numbers at 301–650–8660. Onsite 

registration will be based on space 

availability. 

Requests for Oral Presentations: 

Interested persons who would like to 

make oral comments during the meeting 

will be given 5 minutes to do so if they 

submit their request by October 27, 

2010, to Cathy Fomous. Send requests 

by e-mail to cfomous@od.nih.gov; by fax 

to 301–496–9839; or via postal service 

to Cathy Fomous, Ph.D., Office of 

Biotechnology Activities, National 

Institutes of Health, 6705 Rockledge Dr., 

Suite 750, Bethesda, MD 20892. The 

request should include the commenter’s 

name, title, affiliation, address, e-mail 

address, and telephone number. All 

requests should indicate which 

questions outlined below in the section 

on Public Meeting Focus will be 

addressed. Depending on the number of 

individuals and organizations that 

submit requests to make oral remarks, 

the allotted time may be expanded or 

shortened to provide all interested 

parties an opportunity to present. 

Written Comments: Interested persons 

who cannot attend the meeting may 

submit written comments on the 

questions outlined below. Comments 

should be submitted to Cathy Fomous 

via e-mail, fax, or postal service using 

the above contact information. The 

comment period for written comments 

closes on November 12, 2010. 

Contacts: For questions about the 

meeting logistics, please contact Ms. 

Nicole Numbers at 

numbers@palladianpartners.com or 

301–650–8660. For special 

accommodations or questions about the 

meeting agenda and public comments, 

please contact Cathy Fomous, Ph.D., 

NIH Office of Biotechnology Activities 

at cfomous@od.nih.gov or 301–496– 

9838. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Advances in the knowledge of genetic 

factors involved in health and disease 

have been accompanied by a rapid rise 

in the availability of genetic tests, 

including those tests that diagnose or 

assess the risk for disease, provide 

prognostic information, and guide the 

selection of drug therapies and dosing. 

Although more than 2,000 genetic tests 

are available, there is no public resource 

that provides centralized information 

about the availability and scientific 

basis of these tests. 

On March 18, 2010, the National 

Institutes of Health (NIH) announced its 

intent to develop the Genetic Testing 


erowe on DSK5CLS3C1PROD with NOTICES
Federal Register / Vol. 75, No. 195 / Friday, October 8, 2010 / Notices 62407 

Registry (GTR) to provide access to 

information that enables informed 

decision making by patients, caregivers, 

health care professionals, clinical 

laboratory professionals, payers, and 

policy makers. The goals of the GTR are 

to promote transparency by encouraging 

test providers to share information 

about the purpose and validity of their 

tests; provide a resource for the public— 

including health care providers, 

patients, and researchers—to locate 

laboratories that offer particular tests; 

and facilitate genomic data sharing for 

research and new scientific discoveries. 

The GTR project is overseen by the 

NIH Office of the Director. The National 

Center for Biotechnology Information 

(NCBI), part of the National Library of 

Medicine at NIH, is responsible for 

developing the registry, which is 

expected to be available in 2011. 

As part of the development process, 

the NIH issued a Request for 

Information (RFI) on July 12, 2010, to 

seek input from the public on its plan 

for this project. The RFI comment 

period ended August 2, 2010. NIH 

received 68 comments in response to 

the RFI, and these comments are 

available at http://oba.od.nih.gov/gtr/ 

gtr_comments.html. 

II. Public Meeting Focus 

NIH will begin the November 2 public 

meeting with an overview of the public 

comments that were received in 

response to the RFI and a presentation 

of prototype data elements for the GTR. 

The remainder of the meeting will be 

dedicated to a moderated discussion of 

responses to specific questions about 

the GTR. The meeting agenda will be 

available on the Internet at http:// 

oba.od.nih.gov/gtr/gtr_meetings.html. 

The RFI comments have been helpful 

in the development of a prototype of 

registry data elements. However, NIH 

seeks further public input on specific 

aspects of the GTR and requests that 

comments address the questions below. 

If time permits, discussion of additional 

issues will be accommodated. 

1. Based on an analysis of RFI 

comments and other operational issues, 

NIH is considering a phased approach to 

developing the GTR in which some 

types of tests would be eligible for early 

entry in the GTR and other types of tests 

would be added later. If NIH adopts this 

approach, what criteria should be used 

to determine which genetic tests should 

be included in the first phase of the 

GTR, and what types of tests would 

meet these criteria? 

2. Several RFI responders, who are 

potential data submitters, noted that it 

makes more sense for clinicians and 

genetics professionals to be the source 

of clinical utility evidence rather than 

test developers and/or test providers. 

Given that data submitters are unlikely 

to have clinical utility information, how 

is this data element best addressed in 

the GTR? 

3. Among responders to the RFI 

question about including a data element 

for test cost, half were in favor of 

including cost information and half 

were opposed. What are the benefits, 

risks, and challenges of including cost 

information in the GTR? 

4. What safeguards can be put in place 

to prevent GTR users from 

misunderstanding, misinterpreting, or 

misusing the information in the 

Registry? 

5. What mechanisms can be used to 

provide materials that explain the GTR’s 

data elements to audiences with varying 

technical expertise? 

Dated: October 5, 2010. 

Amy P. Patterson, 

Acting Associate Director for Science Policy, 

NIH. 

[FR Doc. 2010–25411 Filed 10–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Administration; SingleSource Cooperative Agreement Award; 

Announcing the Award a SingleSource Cooperative Agreement to the 

Johns Hopkins University, Applied 

Physics Lab (APL) and School of 

Public Health, To Support the 

Development of a Human Services 

National Interoperable Architecture 

AGENCY: Office of Information Services, 

OA, ACF, HHS. 

ACTION: Notice. 

CFDA Number: 93.647. 

Legislative Authority: This award will 

be made pursuant to the Patient 

Protection and Affordable Care Act 

(ACA) [Pub. L. 111–148] and the 

Improper Payments Elimination and 

Recovery Act of 2010 [Pub. L. 111–204]. 

Amount of Award: $1,500,000. 

Project Period: September 17, 2010 

through September 16, 2011. 

SUMMARY: The Administration for 

Children and Families (ACF), Office of 

Administration (OA), Office of 

Information Services (OIS) announces 

the award of a single-source cooperative 

agreement to the Johns Hopkins 

University (JHU), Applied Physics Lab 

(APL) and School of Public Health, in 

Baltimore, MD, to support the 

development of a Human Services 

National Interoperable Architecture. 

Under the award, APL will develop an 

architectural framework that will be 

used as a model to facilitate State and 

local agencies in information exchanges 

among eligibility and verification 

services that are developed by the HHS/ 

Centers for Medicare and Medicaid 

Services (CMS) under the requirements 

of the Patient Protection and Affordable 

Care Act (ACA). 

To address issues related to 

implementation of the ACA and the 

Improper Payments and Recovery Act of 

2010, the Administration has directed 

Agencies to begin to design and execute 

plans related to the legislation. Under 

ACA, CMS has been directed to create 

a technical solution that enables healthrelated eligibility and enrollment 

functions and to ensure that the human 

services agencies can use the solutions 

for human services eligibility and 

verification determination. Under the 

Improper Payments and Recovery Act of 

2010, Agencies must design and begin 

the execution of plans to eliminate 

improper payments and fraud. 

JHU will create the development of a 

conceptual information technology 

architecture with ACF/Office of 

Information Services. The project will 

produce a solution that supports 

information exchanges and 

interoperability that will lead to 

reductions in improper payments as a 

preventative step in the program 

integrity process. 

FOR FURTHER INFORMATION CONTACT: 

David Jenkins, Federal Project Officer, 

Office of Administration, Office of 

Information Services, Administration 

for Children and Families, 901 D Street, 

SW., 3rd Floor West, Washington, DC 

20047; E-mail: 

David.Jenkins@acf.hhs.gov; Telephone: 

(202) 690–5802. 

Dated: October 1, 2010. 

Michael Curtis, 

Director, Office of Information Services. 

[FR Doc. 2010–25429 Filed 10–7–10; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[USCG–2009–0560] 

Collection of Information Under 

Review by Office of Management and 

Budget: OMB Control Number: 1625– 

New 

AGENCY: Coast Guard, DHS. 


erowe on DSK5CLS3C1PROD with NOTICES